Benitec Biopharma (BNTC)

• Market cap: $381M
• 1 day: -2.03%
• 5 days: 8.82%
• 1 month: 1.93%
• 3 months: -7.58%
• 6 months: -10.56%
• Year to date: -11.83%
• 1 year: -29.52%
• 5 years: -85.06%
• 10 years: -96.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Employees: 19